|
Predicted risk
|
N
|
Mean predicted risk
|
Observed mortality risk
|
Clinical validation
|
PSEP (95% CI)
|
|---|
|
Model 1
| | | | |
57 (31 to 84)
|
|
<40%
|
159
|
22.7%
|
24.5%
|
75.5%a
| |
|
40% to 80%
|
114
|
56.2%
|
54.5%
| | |
|
>80%
|
11
|
86.6%
|
81.8%
|
81.8%b
| |
|
Total population
| | |
38.7%
| | |
|
Model 2
| | | | |
61 (43 to 80)
|
|
<40%
|
148
|
15.7%
|
19.6%
|
80.4%a
| |
|
40% to 80%
|
94
|
56.9%
|
57.4%
| | |
|
>80%
|
21
|
87.1%
|
81.0%
|
81.0%b
| |
|
Total population
| | |
38.0%
| | |
- aNegative predictive value for the low-risk group (<40%). bPositive predictive value for the high-risk group (>80%). CI, confidence interval; n, number of patients in risk group; PSEP, prognostic separation index.
